Related Experiment Video
Updated: May 11, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects
Zhenzhou Jiang1, Meijuan Wu, Jingshan Miao
1Jiangsu Center for Drug Screening, China Pharmaceutical University, Nanjing 210009, PR China.
Abstract:
A functioning vascular supply is essential for solid tumor growth and metastases, which means that blood vessels are an ideal target for antitumor drug discovery. Targeting tumor vasculature involves two main approaches, anti-angiogenesis and vascular disruption. The anti-angiogenic and vascular disrupting activities of deoxypodophyllotoxin (DPT), a natural microtubule destabilizer, were examined with several in vitro, ex vivo and/or in vivo models. First, we demonstrated that DPT significantly inhibits the proliferation, migration and tube formation of endothelial cells and inhibits angiogenesis in rat aortic ring and chick chorioallantoic membrane assays. In further studies, DPT induced cytoskeleton reorganization in endothelial cells, which likely contributed to the anti-angiogenic effect at non-cytotoxic concentrations. DPT treatment at higher concentrations for longer time induced the cell cycle arrest, which may contributes to its anti-proliferation effect and anti-angiogenic activity. And DPT dramatically inducted the expression of cyclin B1 and p21 (WAF1/CIP1). Meanwhile, DPT disrupted capillary-like networks in vitro and newly formed vessels from rat aortic rings. Endothelial cell contraction associated with an increase in F-actin via the Rho/Rho kinase pathway likely contributed to the vascular disrupting activity. Taken together, our results provided the initial evidence that DPT exerts potent anti-angiogenic and vascular disrupting effects. This study also provides important insight into the mechanism of action of promising new anticancer drugs with both anti-angiogenic and vascular disrupting activities.
Insights
Deoxypodophyllotoxin (DPT) shows potent anti-angiogenic and vascular disrupting effects, inhibiting tumor blood vessel formation and growth. This natural compound offers a promising strategy for novel anticancer drug development targeting tumor vasculature.
Area of Science:
- Pharmacology
- Cancer Biology
- Molecular Biology
Background:
- Tumor vascularization is crucial for solid tumor growth and metastasis.
- Targeting tumor vasculature is a key strategy in anticancer drug discovery, employing anti-angiogenesis and vascular disruption.
- Deoxypodophyllotoxin (DPT), a natural microtubule destabilizer, has potential anticancer properties.
Purpose of the Study:
- To investigate the anti-angiogenic and vascular disrupting activities of deoxypodophyllotoxin (DPT).
- To elucidate the mechanisms underlying DPT's effects on endothelial cells and tumor vasculature.
Main Methods:
- In vitro assays: endothelial cell proliferation, migration, tube formation, capillary-like network disruption.
- Ex vivo assays: rat aortic ring assay for angiogenesis inhibition and vascular disruption.
- In vivo assay: chick chorioallantoic membrane assay for angiogenesis inhibition.
- Molecular analysis: cytoskeleton reorganization, cell cycle arrest, protein expression (cyclin B1, p21), Rho/Rho kinase pathway.
Main Results:
- DPT significantly inhibited endothelial cell proliferation, migration, and tube formation.
- DPT demonstrated anti-angiogenic effects in rat aortic ring and chick chorioallantoic membrane assays.
- DPT induced cytoskeleton reorganization and cell cycle arrest in endothelial cells at non-cytotoxic and higher concentrations, respectively.
- DPT disrupted capillary-like networks in vitro and newly formed vessels in rat aortic rings, involving endothelial cell contraction via the Rho/Rho kinase pathway.
Conclusions:
- Deoxypodophyllotoxin (DPT) exhibits significant anti-angiogenic and vascular disrupting properties.
- DPT's mechanisms involve inhibiting endothelial cell functions, inducing cell cycle arrest, and disrupting vascular networks.
- DPT represents a promising candidate for developing novel anticancer drugs targeting tumor vasculature.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Drugs that Destabilize Microtubules
Mechanism of Angiogenesis
Antihypertensive Drugs: Vasodilators
Cytotoxic Edema: Pathophysiology
Drugs that Stabilize Microtubules
